Fertility Germline Testing denied as non-formulary by Cigna?

Cigna's specific coverage criteria for fertility germline testing are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Issues a Non-Formulary Denial for Germline Testing — and How to Appeal

Germline genetic tests are not pharmaceutical drugs, but when billed under certain laboratory or pharmacy benefit codes, Cigna's systems may route them through a formulary-tier review and return a non-formulary denial. This can also occur when a specific laboratory or testing panel is not on Cigna's preferred laboratory list. The result is a denial that looks like a formulary exclusion even though the test has established clinical utility.

## Why This Denial Is Appealable

Non-formulary denials in the diagnostic/laboratory context are routinely overturned on appeal when you can show (a) no clinically equivalent alternative exists on the preferred list, or (b) the specific test methodology is required for your clinical situation. Non-formulary status does not mean "not covered" — it typically means a higher cost-share or a requirement to justify deviation from the preferred option.

## Your Federal Appeal Rights

• Internal appeal: File under ERISA §503 or state law within the deadline shown on your EOB (commonly 180 days).
• External review: ACA §2719 external review is available once internal remedies are exhausted. An accredited IRO issues a binding decision. The overall window from denial to external-review resolution is approximately four months; expedited review (72-hour decision) is available when medically urgent.

## Concrete Appeal Steps and Timeline

1. Identify the specific denial basis — confirm whether the denial is "not on preferred lab list" or "non-covered test code." The language matters for your rebuttal. 2. Ask for the formulary/preferred-lab list — you are entitled to a copy of the criteria used. 3. File internal appeal with the documentation below, within the EOB deadline. 4. Escalate to external review if upheld internally.

## Documentation to Gather

• Ordering physician letter: Explains why the specific laboratory or panel was selected and why no listed alternative provides equivalent clinical information for this patient.
• Clinical indication records: Diagnosis notes, specialist consultations, and any prior test results that establish the medical context.
• Laboratory clinical-utility statement: Many reference labs provide peer-reviewed evidence summaries; attach the one relevant to your test.
• Absence-of-equivalent documentation: A written statement that no preferred-list test addresses the specific clinical question (e.g., a particular gene panel or methodology).

## Criteria-Mapping Structure

Obtain Cigna's published medical and administrative policy for the test code billed. List each coverage requirement and each preferred-alternative criterion. For every item, document your chart-based answer. Where the preferred alternative is clinically insufficient, state exactly why — in the physician's own words from the medical record — rather than with generic assertions. A requirement-by-requirement response is significantly harder for Cigna to uphold than a narrative letter alone.